Development and testing of retroviral vectors expressing multimeric hammerhead ribozymes targeted against all major clades of HIV-1.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Frontiers in Bioscience

• Publication date

  2002-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2741/RAMEZANIPMID 11815297
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expansion of human cord blood CD34(+)CD38(-) cells in ex vivo culture during retroviral transduction without a corresponding increase in SCID repopulating cell (SRC) frequency: dissociation of SRC phenotype and function.

  2000influential reference
• Current developments and future prospects for HIV gene therapy using interfering RNA-based strategies.

  2000cited by this paper
• Potential nuclease-based strategies for HIV gene therapy.

  2000cited by this paper
• Amelioration of Retroviral Vector Silencing in Locus Control Region β-Globin-Transgenic Mice and Transduced F9 Embryonic Cells

  1999cited by this paper
• RNA-polymerase III-driven expression cassettes in human gene therapy.

  1999cited by this paper
• Targeted RNases: a feasibility study for use in HIV gene therapy

  1999cited by this paper
• Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses.

  1997cited by this paper
• Inhibition of HIV-1 replication by retroviral vectors expressing monomeric and multimeric hammerhead ribozymes

  1997influential reference
• A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells

  1997influential reference
• Comparative Analysis of Five Highly Conserved Target Sites Within the HIV-1 RNA for Their Susceptibility to Hammerhead Ribozyme-Mediated Cleavage In Vitro and In Vivo

  1996cited by this paper
• Fusion with an RNA binding domain to confer target RNA specificity to an RNase: design and engineering of Tat-RNase H that specifically recognizes and cleaves HIV-1 RNA in vitro.

  1996cited by this paper
• Gene therapy for HIV infection.

  1996cited by this paper
• Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11.

  1996cited by this paper
• Gene therapy for HIV infection.

  1995cited by this paper
• Genetic instability of a MoMLV-based antisense double-copy retroviral vector designed for HIV-1 gene therapy.

  1995cited by this paper
• Lack of expression from a retroviral vector after transduction of murine hematopoietic stem cells is associated with methylation in vivo.

  1994cited by this paper
• Inhibition of HIV-1 Multiplication in a Human CD4+ Lymphocytic Cell Line Expressing Antisense and Sense RNA Molecules Containing HIV-1 Packaging Signal and Rev Response Element(s)

  1994cited by this paper
• Gene therapy for infectious diseases: the AIDS model.

  1994cited by this paper
• Versatile retroviral vectors for potential use in gene therapy.

  1994cited by this paper
• The Development and Testing of Retroviral Vectors Expressing Trans-Dominant Mutants of HIV-1 Proteins to Confer Anti-HIV-1 Resistance

  1993cited by this paper
• Transplantable myeloproliferative disease induced in mice by an interleukin 6 retrovirus

  1992cited by this paper
• Multitarget-ribozyme directed to cleave at up to nine highly conserved HIV-1 env RNA regions inhibits HIV-1 replication--potential effectiveness against most presently sequenced HIV-1 isolates.

  1992influential reference
• Efficient replication, integration, and packaging of retroviral vectors with modified long terminal repeats containing the packaging signal.

  1990cited by this paper
• HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy.

  1989cited by this paper
• Simple RNA enzymes with new and highly specific endoribonuclease activities

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus.

  1987cited by this paper
• Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

  1986cited by this paper

• HIV Entry and Its Inhibition by Bifunctional Antiviral Proteins

  2018cites this paper
• Control of HIV Infection In Vivo Using Gene Therapy with a Secreted Entry Inhibitor

  2017cites this paper
• Small RNA Molecules in Antiviral Therapy

  2014cites this paper
• Small RNA–Mediated Transcriptional Modulation

  2014cites this paper
• A novel gene therapy strategy using secreted multifunctional anti-HIV proteins to confer protection to gene-modified and unmodified target cells

  2013cites this paper
• Zinc Finger Protein Designed to Target 2-Long Terminal Repeat Junctions Interferes with Human Immunodeficiency Virus Integration

  2012influential citation
• Nucleic Acids as Regulatory Molecules

  2010cites this paper
• HIV-1 gene therapy at pre-integration and provirus DNA levels.

  2009cites this paper
• RNA AND DNA INACTIVATION STRATEGIES TO PREVENT OR INHIBIT HIV-1 REPLICATION VIA GENE THERAPY

  2008cites this paper
• Gentherapie

  2008cites this paper
• Inhibition of human immunodeficiency virus-1 entry using vectors expressing a multimeric hammerhead ribozyme targeting the CCR5 mRNA.

  2008influential citation
• Trafficking through the Rev/RRE Pathway Is Essential for Efficient Inhibition of Human Immunodeficiency Virus Type 1 by an Antisense RNA Derived from the Envelope Gene

  2008cites this paper
• Trafficking through the Rev/RRE Pathway Is Essential for Efficient Inhibition of Human Immunodeficiency Virus Type 1 by an Antisense RNA Derived from the Envelope Gene (cid:1)

  2008cites this paper
• Effective Anti-Hepatitis B Virus Hammerhead Ribozymes Derived from Multimeric Precursors

  2007cites this paper
• Assessment of an anti-HIV-1 combination gene therapy strategy using the antisense RNA and multimeric hammerhead ribozymes.

  2006cites this paper
• RNA as a target for host defense and anti-HIV drugs.

  2006cites this paper
• Gene therapy progress and prospects: Novel gene therapy approaches for AIDS

  2005cites this paper
• Prospects for antiviral ribozymes and deoxyribozymes

  2004cites this paper